Kamal Hamed, Chief Officer of Spero Therapeutics SPRO, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/02/02.

KH

KH

Kamal Hamed

Chief Medical Officer

Company

Spero Therapeutics SPRO

First filing

23/02/03

Trades

5 trades

Buys / sales

0 / 2

12-month net buying

No record

Last trade

24/02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Spero TherapeuticsSPRO	Open-market sale	24/02/02	24/02/05	28,075 sh	$1.37	$38,462.75	−3.4%
Spero TherapeuticsSPRO	Open-market sale	23/09/13	23/09/15	39,496 sh	$1.27	$50,159.92	−6.4%